The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY
for the assessment of cerebral and myocardial glucose metabolism in various physiological
or pathological states including stroke and myocardial ischemia. It is also employed
for the detection of malignant tumors including those of the brain, liver, and thyroid
gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
Qualificatifs autorisés : IP / IM / PK / TU / AG / BL / CF / CS / CH / UR / RE / HI
/ AN / CL / EC / PD / ST / AD / AI / AA / SD / PO / AE / TO / ME2005(1978)
Informations sur la notice
Identifiant de la notice : 04084207X
RCR créateur de la notice : 0001
Date de création : 23-09-1998
RCR dernier modificateur de la notice : 1999
Date de dernière modification : 26-11-2024 à 16 h 08